[1] 李良山, 杨丽, 李扬, 等. CT引导下经皮穿刺腹膜活检对不明原因腹腔积液的诊断价值[J]. 局解手术学杂志, 2017,26(3):201-203. Li L S, Yang L, Li Y, et al. Diagnostic value of CT-guided percutaneous peritoneal biopsy for unexplained peritoneal effusion[J]. Journal of Local Surgery, 2017,26(3):201-203.
[2] 李晓东, 郑晓萌, 曹艳霞, 等. 18F-FDG符合线路显像联合肿瘤标志物检测对腹水的诊断价值[J]. 河北医药, 2015,37(11):1609-1612. Li X D, Zheng X M, Cao Y X, et al. Diagnostic value of 18F-FDG coincidence imaging combined with detection of tumor markers for ascites[J]. Hebei Medicine, 2015,37(11):1609-1612.
[3] 韩娜,兰晓莉. 18F-FDG PET/CT及其他影像学技术在不明原因腹水中的应用价值[J]. 华中科技大学学报(医学版), 2017,46(4):489-493. Han N, Lan X L. Application value of 18F-FDG PET/CT and other imaging techniques in unexplained ascites[J]. Journal of Huazhong University of Science and Technology (Medical Edition), 2017,46(4):489-493.
[4] 张蓉琴, 尹吉林, 李向东, 等. 18F-FDG PET/CT显像诊断不明原因腹腔积液[J].中国医学影像技术, 2016,32(1):79-82. Zhang R Q, Yin J L, Li X D, et al. 18F-FDG PET/CT imaging in the diagnosis of unexplained peritoneal effusion[J]. Chinese Medical Imaging Technology, 2016,32(1):79-82.
[5] Shim S W, Shin S H, Kwon W J, et al. CT differentiation of female peritoneal tuberculosis and peritoneal carcinomatosis from normal-sized ovarian cancer[J]. Journal of Computer Assisted Tomography, 2017,41(1):32-38.
[6] Han S, Kim H, Kim Y J, et al. Prognostic value of volume-based metabolic parameters of 18F-FDG PET/CT in ovarian cancer:a systematic review and meta-analysis[J]. Annals of Nuclear Medicine, 2018,32(10):669-677.
[7] 陆佩欧, 王文志, 李迎辞, 等. 18F-FDG PET/CT对不明原因腹腔积液的临床应用价值[J]. 实用肿瘤学杂志, 2016,30(2):114-117. Lu P O, Wang W Z, Li Y C, et al. Clinical application value of 18F-FDG PET/CT in unexplained ascites[J]. Journal of Applied Oncology, 2016,30(2):114-117.
[8] Han N, Sun X, Qin C, et al. Value of 18F-FDG PET/CT combined with tumor markers in the evaluation of ascites[J]. American Journal of Roentgenology, 2018,210(5):1155-1163.
[9] Akin E A, Kuhl E S, Zeman R K. The role of FDG-PET/CT in gynecologic imaging:an updated guide to interpretation and challenges[J]. Abdominal Radiology, 2018,43(9):2474-2486.
[10] Chen R, Chen Y, Liu L, et al. The role of 18F-FDG PET/CT in the evaluation of peritoneal thickening of undetermined origin[J]. Medicine (Baltimore), 2016,95(15):e3023.
[11] Liu S, Ju X, Feng Z, et al. Tumor-to-background ratios of the maximum standardized uptake value could not indicate the prognosis of advanced high-grade serous ovarian cancer patients[J]. Nuclear Medicine Communications, 2018,39(4):319-324.
[12] Sookha R R, Zhi W H, Shen Y X, et al. Clinical value of combining 18F-FDG PET/CT and routine serum tumor markers in the early detection of recurrence among follow-up patients treated for cervical squamous cell carcinoma[J]. Journal of Cancer, 2018,9(17):3101-3108.
[13] 张惠琴. 肿瘤标志物联合检测对恶性胸腹腔积液的诊断价值[J]. 国际检验医学杂志, 2015,36(21):3131-3132, 3136. Zhang H Q. Diagnostic value of combined detection of tumor markers for malignant pleural and peritoneal effusion[J]. International Journal of Laboratory Medicine, 2015,36(21):3131-3132, 3136.
[14] Morales-Vásquez F, Pedernera E, Reynaga-Obregón J, et al. High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma[J]. Journal of Ovarian Research, 2016,9(1):41.
[15] 李正民, 贺静, 代淑阳, 等. CA125在非妇科疾病中的临床应用价值[J].中国实验诊断学, 2018,22(5):913-916. Li Z M, He J, Dai S Y, et al. Clinical application value of CA125 in non-gynecological diseases[J]. Chinese Experimental Diagnostics, 2018,22(5):913-916. |